GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cengild Medical Bhd (XKLS:0243) » Definitions » EV-to-EBITDA

Cengild Medical Bhd (XKLS:0243) EV-to-EBITDA : 9.53 (As of Jun. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cengild Medical Bhd EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cengild Medical Bhd's enterprise value is RM188.12 Mil. Cengild Medical Bhd's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was RM19.74 Mil. Therefore, Cengild Medical Bhd's EV-to-EBITDA for today is 9.53.

The historical rank and industry rank for Cengild Medical Bhd's EV-to-EBITDA or its related term are showing as below:

XKLS:0243' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.63   Med: 12.66   Max: 32.72
Current: 9.53

During the past 6 years, the highest EV-to-EBITDA of Cengild Medical Bhd was 32.72. The lowest was 7.63. And the median was 12.66.

XKLS:0243's EV-to-EBITDA is ranked better than
65.03% of 469 companies
in the Healthcare Providers & Services industry
Industry Median: 12.48 vs XKLS:0243: 9.53

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-24), Cengild Medical Bhd's stock price is RM0.315. Cengild Medical Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was RM0.015. Therefore, Cengild Medical Bhd's PE Ratio for today is 21.00.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Cengild Medical Bhd EV-to-EBITDA Historical Data

The historical data trend for Cengild Medical Bhd's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cengild Medical Bhd EV-to-EBITDA Chart

Cengild Medical Bhd Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBITDA
Get a 7-Day Free Trial - - - 14.82 11.54

Cengild Medical Bhd Quarterly Data
Jun18 Jun19 Jun20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.63 11.54 10.97 9.74 9.11

Competitive Comparison of Cengild Medical Bhd's EV-to-EBITDA

For the Medical Care Facilities subindustry, Cengild Medical Bhd's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cengild Medical Bhd's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cengild Medical Bhd's EV-to-EBITDA falls into.



Cengild Medical Bhd EV-to-EBITDA Calculation

Cengild Medical Bhd's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=188.120/19.737
=9.53

Cengild Medical Bhd's current Enterprise Value is RM188.12 Mil.
Cengild Medical Bhd's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM19.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cengild Medical Bhd  (XKLS:0243) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cengild Medical Bhd's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.315/0.015
=21.00

Cengild Medical Bhd's share price for today is RM0.315.
Cengild Medical Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.015.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Cengild Medical Bhd EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cengild Medical Bhd's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cengild Medical Bhd (XKLS:0243) Business Description

Traded in Other Exchanges
N/A
Address
No.7, Jalan Kerinchi, Unit 2-3 & 2-4, Level 2, Nexus, Bangsar South, Kuala Lumpur, MYS, 59200
Cengild Medical Bhd is a healthcare service provider operating a medical centre specialising in the diagnosis and treatment of gastrointestinal related oncology and gynaecology services., liver diseases and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.

Cengild Medical Bhd (XKLS:0243) Headlines

No Headlines